According to Ultragenyx Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โน64.25 Billion. In 2025 the company made a revenue of โน60.38 Billion an increase over the revenue in the year 2024 that were of โน48.06 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.